Current Report Filing (8-k)
07 February 2023 - 09:29AM
Edgar (US Regulatory)
0001872356 false 0001872356 2023-01-31
2023-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of report (date of earliest event reported): February 6,
2023 (January
31, 2023)
|
Molekule Group, Inc. |
| (Exact
name of registrant as specified in its charter) |
|
Delaware |
|
001-41096 |
|
45-3213164 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer Identification No.) |
10455 Riverside Dr.
Palm Beach Gardens,
FL |
|
33410 |
|
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s telephone number, including area code: (833)
652-5326
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
| |
¨ |
Written
communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425) |
| |
¨ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12) |
| |
¨ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
| |
¨ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the
Act:
|
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
|
Common Stock, par value $0.01 per share |
|
MKUL |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
x
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Principal Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
Molekule Group, Inc. (the “Company”) has agreed with Mr. Jonathan
Harris, its chief commercial officer, that Mr. Harris’s last day of
employment with the Company was effective as of January 31, 2023.
In connection with his departure from the Company, Mr. Harris has
entered into a separation agreement with the Company which provides
that (1) Mr. Harris will receive a lump sum payment of six months
of base salary ($175,000), (2) Mr. Harris will retain his 106,710
vested RSUs, which will settle in accordance with their terms
within 30 days following July 12, 2023, and will forfeit his
unvested RSUs and (3) Mr. Harris will receive medical and dental
benefits for a specified period of time.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
Dated: February 6, 2023
| |
MOLEKULE
GROUP, INC. |
| |
|
|
| |
|
|
| |
By: |
/s/
Jason DiBona |
| |
|
Name:
Jason DiBona |
| |
|
Title: Chief
Executive Officer |
AeroClean Technologies (NASDAQ:AERC)
Historical Stock Chart
From May 2023 to Jun 2023
AeroClean Technologies (NASDAQ:AERC)
Historical Stock Chart
From Jun 2022 to Jun 2023
